Explaining Stewart v. Azar: Implications of the Court’s Decision on Kentucky’s Medicaid Waiver

Issue Brief
  1. Federal law requires that expansion enrollees receive a benefit package with the ACA’s 10 essential health benefits, including prescription drugs. 42 U.S.C. §§ 1396a(k)(1); 1396u-7(b)(5); 18022(b)(1)(F); 42 C.F.R. § 440.347(a)(6).

    ← Return to text

  2. Sec’y Adam Meier, Cabinet for Health & Family Servs., Kentucky HEALTH 1115 Medicaid Waiver Rollout Update, Interim Joint Comm. on Health & Welfare & Family Servs., Meeting 1, June 20, 2018, http://www.lrc.ky.gov/CommitteeMeetingDocuments/7/11398/June%2020%202018%20CHFS%201115%20Update.pdf.

    ← Return to text

  3. In deciding whether to stay the decision, the court would consider the likelihood that HHS and Kentucky will ultimately prevail on the merits, the prospect of irreparable injury if relief is withheld, the possibility of harm to the plaintiffs if relief is granted, and the public interest. U.S. Court of Appeals for the DC Circuit, Circuit Rule 8(a)(1).

    ← Return to text

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.